期刊文献+

冠状动脉内逆向精确溶栓术在急性ST段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗中应用的研究 被引量:25

Application of Precise Intracoronary Retrograde Thrombolysis During Primary PCI in Patients With Acute ST-segment Elevation Myocardial Infarction
下载PDF
导出
摘要 目的:通过与血栓抽吸术对比,探讨冠状动脉内逆向精确溶栓术在急性ST段抬高型心肌梗死(STEMI)患者行直接经皮冠状动脉介入治疗(PCI)术中应用的安全性和有效性。方法:连续入选2014-01至2015-12在解放军总医院心脏介入中心确诊急性STEMI并行直接PCI术的患者123例,随机分为冠状动脉内逆向精确溶栓术组(逆向溶栓组,n=60)和血栓抽吸术组(血栓抽吸组,n=63),其中血栓抽吸组有3例患者因未能完成血栓抽吸术而被剔除出组。主要终点为直接PCI术后无复流的发生率及术后60~90 min内心电图ST段回落≥50%的比例;主要安全终点为住院期间脑卒中和心肌梗死溶栓治疗临床试验(TIMI)出血发生率。结果:(1)逆向溶栓组术后无复流发生率显著低于血栓抽吸组(1.7%vs 15.0%,P=0.008),术后心电图ST段回落≥50%的比例及超声测得的左心室射血分数显著高于血栓抽吸组[65.0%vs 45.0%,P=0.028;(50.7±8.6)%vs(46.7±8.3)%,P=0.011],差异均具有统计学意义。两组患者住院期间主要不良心血管事件发生率差异无统计学意义(P〉0.05)。(2)两组患者住院期间均未发生脑卒中及TIMI出血事件。结论 :同血栓抽吸术相比,冠状动脉内逆向精确溶栓术在急性STEMI患者行直接PCI术中应用具有相似的安全性,但可减少无复流的发生并能改善左心室心功能。 Objective: In comparison with thrombus aspiration, to study the safety and efficacy of precise intracoronary retrograde thrombolysis during primary percutaneous coronary intervention(PCI) in patients with acute ST-segment elevation myocardial infarction(STEMI).Methods: A total of 123 consecutive patients with acute STEMI received primary PCI in our hospital from 2014-01 to 2015-12 were enrolled.The patients were randomly divided into 2 groups: RT group, the patients received precise intracoronary retrograde thrombolysis(RT), n =60 and TA group, the patients received thrombus aspiration(TA), n =63, among them, 3 patients with failed TA were excluded. Primary end points included occurrence rates of no-flow after PCI and ST-segment resolution(STR)≥50% at(60-90) min after PCI; primary safety end points included occurrence rates of in-hospital stroke and TIMI-hemorrhage events.Results:(1) Compared with TA group, RT group showed decreased no-flow rate after PCI(1.7% vs 15.0%), P=0.008 and increased rate of STR≥50% after PCI(65.0% vs 45.0%), P=0.028, improved LVEF by echocardiography(50.7±8.6) % vs(46.7±8.3)%, P=0.011. The in-hospital MACE occurrence rate was similar between 2 groups, P〈0.05.(2) No in-hospitalstroke or TIMI-hemorrhage events occurred in neither group.Conclusion: Intracoronary retrograde precise thrombolysis had the similar safety to thrombus aspiration during primary PCI in patients with acute STEMI, it may reduce no-reflow rate and improve left ventricular function after PCI.
出处 《中国循环杂志》 CSCD 北大核心 2016年第12期1160-1164,共5页 Chinese Circulation Journal
关键词 心肌梗死 血管成形术 经腔 经皮冠状动脉 血栓溶解疗法 Myocardial infarction Angioplasty transluminal percuteanous coronary Thrombolysis
  • 相关文献

参考文献3

二级参考文献12

  • 1韩雅玲.中国经皮冠状动脉介入治疗指南2012(简本)[J].中国医学前沿杂志(电子版),2012,4(12):50-59. 被引量:133
  • 2Eeckhout E,Kern MJ.The coronary no-reflow phenomenon:a review of mechanisms and therapies.Eur Heart J,2001,22:729-739. 被引量:1
  • 3Galuto L.Optimal therapeutic strategies in the setting of post-infarct no reflow; the need for a pathogenetic classification.HEART,2004,90:123-125. 被引量:1
  • 4Kloner RA,Ganote CE,Jennings RB,The "no-reflow" phenomenon after temporary coronary occlusion in the dog.J Clin Invest,1974,54:1496-1508. 被引量:1
  • 5Byrne JG,Appleyard RF,Lee CC,et al.Controllde reperfusion of the regionally ischemic myocardium with leukocyte-depleted blood reduces stunning,the no-reflow phenomenon,and infarct size.JThorac Cardiovasc Surg,1992,103:66-71. 被引量:1
  • 6Maekawa K,Kawamoto K,Fuke S,et al.Effects of intraaortic balloon pumping on the angiographic no-reflow phenomenon after percutaneous coronary intervention in patients with anterior myocardial infarction.Circ J,2006,70(1):37-43. 被引量:1
  • 7Pasceri V,Patti G,Di Sciascio G.Prevention of myocardial damage during coronary intervention.Cardiovasc Hematol Disord Drug Targets,2006,6(2):77-83. 被引量:1
  • 8Iwakura K,Ito H,Kawano S,et al.Chronic pre-treatment of statins is associated with the reduction of the no-reflow phenomenon in the patients with reperfused acute myocardial infarction.Eur Heart J,2006,27 (5):534-539. 被引量:1
  • 9Zhao JL,Yang YJ,You SJ,et al.Pretreatment with fosinopril or valsartan reduces myocardial no-reflow after acute myocardial infarction and reperfusion.Coron Artery Dis,2006,17 (5):463-469. 被引量:1
  • 10Porto I,Ashar V,Mitchell AR.Pharmacological management of no reflow during percutaneous coronary intervention.Curr Vasc Pharmacol,2006,4(2):95-100. 被引量:1

共引文献65

同被引文献184

引证文献25

二级引证文献125

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部